Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc.
Closing of the Merger Expected in Early August DUBLIN, July 17, 2025 /PRNewswire/ — Mallinckrodt plc today announced that the Irish High Court has given... Read more.
ManpowerGroup Reports 2nd Quarter 2025 Results
Revenues of $4.5 billion (flat as reported, -3% constant currency (CC), -1% organic CC) Latin America and Asia Pacific continued to experience good demand while... Read more.
Valour Enters Swiss Market with HBAR and ICP Staking ETP Listings on SIX Swiss Exchange
Valour Launches First Products on SIX Swiss Exchange: Valour has officially entered the Swiss market with the listing of two staking ETPs—1Valour Hedera (HBAR)... Read more.
Pye-Barker Fire & Safety Acquires Idaho Fire Sprinkler Leader Accurate Fire Protection Solutions
ATLANTA, July 17, 2025 /PRNewswire/ — Pye-Barker Fire & Safety — the largest fully integrated and full-service fire protection, life safety and... Read more.
Why Outdated Tech is Costing Nonprofits More Than They Realize
Legacy donor systems are silently undermining efficiency, donor retention, and long-term impact—while AI-powered, consolidated data platforms are emerging... Read more.
Kyruus Health Expands Reach to Integrate with Bing and Other AI Experiences Consumers Use to Find Care
BOSTON, July 17, 2025 /PRNewswire/ — Building on the successful launch of Reach in October 2024, Kyruus Health, the leading care access platform, today announced... Read more.
BingX Rolls Out VoteX: Community-Driven Futures Listing Initiative
PANAMA CITY, July 17, 2025 /PRNewswire/ — BingX, a leading cryptocurrency exchange and Web3 AI company, today announced the launch of VoteX, an interactive... Read more.
General Glen D. VanHerck Joins C Speed Board of Directors
Former NORAD and USNORTHCOM Commander Brings Strategic Defense Insight to Innovative Radar Company SYRACUSE, N.Y., July 17, 2025 /PRNewswire/ — C Speed,... Read more.
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate
Company aims for technology advancement and platform expansion with Korea’s first influenza vaccine using an adjuvant Interim results from the Phase 1/2 trial... Read more.
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
MINNEAPOLIS, July 17, 2025 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on... Read more.